comparemela.com
  1. Home
  2. Live Updates
  3. Other Otc Silo - Breaking News

Latest Breaking News On - Other otc silo - Page 1 : comparemela.com

Silo Pharma Announces Positive Results in Subcutaneous

ENGLEWOOD CLIFFS, N.J, July 12, 2022 (GLOBE NEWSWIRE) Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announces.

Eric weisblumBrett maasSilo pharma incSilo pharmaPrivate securities litigation reform actRelations contactOther otc siloSilo pharma

Silo Pharma Announces Successful Dosing of Patients

Study is examining effects of Psilocybin on Inflammatory MarkersENGLEWOOD CLIFFS, N.J., May 19, 2022 (GLOBE NEWSWIRE)  Silo Pharma, Inc . (OTCQB:.

Eric weisblumBrett maasUniversity of california san franciscoTranslational psychedelic research trpr programSilo pharma incSilo pharmaCalifornia san franciscoTranslational psychedelic researchForward looking statementsPrivate securities litigation reform actRelations contactOther otc siloSilo pharma

Silo Pharma Produces SPU-21 Liposomes for Rheumatoid

SPU-21 has shown Anti-arthritic activity for therapeutic use in preclinical studies..

Eric weisblumBrett maasSilo pharma incFrontage laboratoriesSilo pharmaRheumatoid arthritisPrivate securities litigation reform actRelations contactOther otc siloSilo pharma

Silo Pharma Enters into Agreement with Contract Research

IND Enabling Study to prepare Silo Pharma Homing Peptides for Clinic.

United statesLos angelesEric weisblumBrett maasCorporate communicationsSilo pharma incFrontage laboratoriesPharmacokinetic studySilo pharmaCentral nervous system peptideJoint homing peptideCentral nervous systemAutoimmune diseasesPrivate securities litigation reform actRelations contactOther otc silo

Silo Pharma Announces Grant of U S Patent For its Novel

U.S. Patent and Trademark Office issued US Patent No. .

Eric weisblumBrett maasUniversity maryland baltimoreSilo pharma incEnglewood cliffsSilo pharmaChief executive officerPrivate securities litigation reform actRelations contactOther otc siloSilo pharma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.